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Abstract
The molecular epidemiology of Helicobacter pylori in Africa is poorly documented. From January 2007 to December 2008, we investi-
gated 187 patients with gastric symptoms in one of the main tertiary hospitals in Dakar, Senegal. One hundred and seventeen patients
were culture-positive for H. pylori. Polymorphisms in vacA and cagA status were investigated by PCR; the 3¢-region of cagA was
sequenced, and EPIYA motifs were identiﬁed. Bacterial heterogeneity within individuals was extensively assessed by using an approach
based on vacA and cagA heterogeneity. Fourteen per cent of H. pylori-positive patients displayed evidence of mixed infection, which may
affect disease outcome. Patients with multiple vacA alleles were excluded from subsequent analyses. Among the ﬁnal study population of
105 patients, 29 had gastritis only, 61 had ulcerated lesions, and 15 had suspicion of neoplasia based on endoscopic ﬁndings. All cases of
suspected neoplasia were histologically conﬁrmed as gastric cancer (GC). The cagA gene was present in 73.3% of isolates. CagA pro-
teins contained zero (3.7%), one (93.9%) or two (2.4%) EPIYA-C segments, and all were western CagA. Most of the isolates possessed
presumed high-vacuolization isotypes (s1i1m1 (57.1%) or s1i1m2 (21.9%)). Despite the small number of cases, GC was associated with
cagA (p 0.03), two EPIYA-C segments in the C-terminal region of CagA (p 0.03), and the s1 vacA allele (p 0.002). Multiple EPIYA-C seg-
ments were less frequent than reported in other countries, possibly contributing to the low incidence of GC in Senegal.
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Introduction
Helicobacter pylori is associated with severe gastroduodenal
disorders, including peptic ulcer disease [1], distal gastric
adenocarcinoma, and gastric mucosa-associated lymphoid tis-
sue lymphoma [2]. Although about half of the world popula-
tion is infected, only a small percentage of colonized
individuals develop such severe disorders, indicating that
outcome is inﬂuenced by H. pylori strain virulence, the host
response, or environmental factors.
A major H. pylori virulence determinant is the cag pathoge-
nicity island (cag PAI) [3], a 40-kb region originally acquired
horizontally and inserted into the glutamate racemase gene.
Genes in the cag PAI encode a type IV secretion system
through which CagA is translocated into gastric epithelial
cells. Once inside the host cell, CagA disrupts signalling
pathways through phosphorylation-dependent and phosphor-
ylation-independent mechanisms, leading to abnormal
proliferation and motility of gastric epithelial cells and to
cytoskeletal changes [3]. CagA undergoes tyrosine phosphor-
ylation by multiple members of the Src family of kinases on
speciﬁc tyrosine residues within repeating Glu-Pro-Ile-Tyr-
Ala (EPIYA) motifs. The EPIYA segments are deﬁned as
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE BACTERIOLOGY
EPIYA-A, EPIYA-B EPIYA-C, and EPIYA-D, according to the
amino acid sequence that surrounds the EPIYA motif. Once
phosphorylated, CagA binds to a cytoplasmic Src homology 2
domain of Src homology 2 phosphatase (SHP-2) and deregu-
lates SHP-2. CagA also binds to and inhibits PAR1b/MARK2
polarity-regulating kinase, disrupting apical junctions and epi-
thelial–basolateral polarity [4,5]. Together, these CagA activi-
ties may contribute to the transformation of gastric epithelial
cells. A second major virulence factor is the VacA cytotoxin,
a protein with multiple effects on host cells [6]. In contrast
to cagA, vacA is present in almost all H. pylori strains. Three
major polymorphic regions have been identiﬁed: the signal
region (s1 and s2), the intermediate region (i1 and i2), and
the middle region (m1 and m2) [6,7]. The mosaic combina-
tion of s-region, m-region and i-region alleles in vacA deter-
mines production of the cytotoxin, as well as its host cell
speciﬁcity and the degree of cytotoxicity [6–8].
As compared with the situation in industrialized countries,
few data are available on the importance of H. pylori viru-
lence factors for clinical outcome in Africa [9–12]. Here, we
examined the potential association of cagA and vacA virulence
factor polymorphisms with H. pylori-related diseases and his-
topathological lesions in symptomatic patients in Senegal.
Materials and Methods
Patients
Patients who suffered from upper abdominal pain were
investigated at the Gastroenterology Department of Le
Dantec Hospital (Dakar, Senegal) between January 2007 and
December 2008. Demographic data, medical history and
presenting symptoms were prospectively collected by the
physician. All patients were of Senegalese origin, and none
had received proton-pump inhibitors or antibiotics during
the 4 weeks before endoscopy. Patients were excluded from
the study if they were culture-negative for H. pylori. Three
biopsy samples were taken from the antrum and three from
the fundus during upper gastrointestinal tract endoscopy.
One biopsy sample from each site was cultured for H. pylori
isolation, and the four others were ﬁxed and processed for
histological analysis. All endoscopes and accessory devices
were decontaminated after every endoscopy, according to
local written procedures. On the basis of endoscopic ﬁnd-
ings, patients were classiﬁed as having gastritis only, ulcer-
ated lesion, or suspicion of neoplasia.
Histology
Histopathological diagnoses were based on the updated Syd-
ney System [13], and the Vienna classiﬁcation for dysplasia
[14]. Written informed consent was obtained from all
patients, and the study protocol was approved by the Sene-
golese national ethics committee.
H. pylori isolation, genomic DNA extraction, and determina-
tion of cagA status and cagA/vacA polymorphisms
H. pylori culture was performed by the use of Wilkins Chal-
gren agar plates with 7% (v/v) deﬁbrinated horse blood and
H. pylori selective antibiotic supplement (Oxoid, Basingstoke,
UK), as previously described [15]. Genomic DNA was
extracted from a mixture of colonies from antrum and fun-
dus samples with a QIAmp kit (Qiagen, Courtaboeuf,
France). Polymorphisms in the s-region, m-region and i-
region of vacA and cagA status were determined as described
elsewhere, using the primers reported in Table 1 [6,7,15,16].
The 3¢-region of cagA, encoding the EPIYA segments, was
sequenced, and the number and type of EPIYA segments
were inferred as previously described [15]. Nucleotide
TABLE 1. List of oligonucleotide primers used
Gene Region ampliﬁed Primer Primer sequence (5¢–3¢) Size (bp) Reference
vacA s1 vA1F GAAATACAACAAACACACCGC 259 [6]
vA1R GGCTTGTTTGAGCCCCCAG
s2 vA1F GAAATACAACAAACACACCGC 286 [6]
vA1R GGCTTGTTTGAGCCCCCAG
m1 vA3F GGTCAAAATGCGGTCATGG 290 [6]
vA3R CATCAGTATTTCGCACCACA
m2 vA4F CCAGGAAACATTGCCGGCAAA 352 [6]
vA4R CATAACTAGCGCCTTGCAC
i1 VacF1-i GTTGGGATTGGGGGAATGCCG 426 [7]
C1R-i TTAATTTAACGCTGTTTGAAG
i2 VacF1-i GTTGGGATTGGGGGAATGCCG 432 [7]
C2R-i GATCAACGCTCTGATTTGA
cagA EPIYA cagA2530S GTTAARAATRGTGTRAAYGG
R = A or G and Y = T or C
Variable [15]
cagA3000AS TTTAGCTTCTGATACCGC
cagA (5¢-region) cagA-F TTGACCAACAACCACAAACCGAAG 183 [16]
cagA-R CTTCCCTTAATTGCGAGATTCC
Empty site 2 ACATTTTGGCTAAATAAACGCTG 360 [16]
25 TCATGCGAGCGGCGATGTG
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sequences were deposited in GenBank under accession num-
bers HM362686–HM362767.
Mixed infections
Patients with multiple vacA alleles were considered to have
mixed infection. For patients with a single vacA allele and
ambiguities after sequencing of the EPIYA PCR product, gas-
tric biopsy samples were defrosted, and ten independent col-
onies were randomly selected from each primary culture
(antrum and fundus) and subcultured. After DNA extraction,
random ampliﬁcation of polymorphic DNA (RAPD) PCR was
used to assess the clonal relationship between isolates from
the same patient, as previously described [17]. Only patients
with identical vacA alleles and EPIYA combinations were sub-
sequently analysed.
Statistical analysis
Microsoft Access 2003 was used for data entry, and Stata
Version 10 (StataCorp, College Station, TX, USA) for statis-
tical analysis. Univariate analysis and logistic regression were
used to identify determinants of ulcerated lesions and gastric
cancer (GC) among H. pylori-positive patients. In both cases,
patients with ulcerated lesions or GC were ﬁrst compared
with patients with any other lesion, and then with patients
with gastritis only on the basis of endoscopic ﬁndings.
In univariate analysis, the chi-square test (or Fisher’s exact
test when appropriate) and Student’s t-test were used to
compare categorical and continuous variables, respectively.
Factors associated with ulcerated lesion or GC in univariate
analysis with p-values £0.2 were retained for multivariate
analysis. A backward stepwise selection procedure was used
to build the models. Interactions were then tested and the
models were assessed with the Hosmer and Lemeshow
goodness-of-ﬁt test. The accuracy of the ﬁnal models was
assessed from the area under the receiver operating charac-
teristic curve, sensitivity, and speciﬁcity, and p-values <0.05
were considered to denote signiﬁcant associations in all anal-
yses.
Results
Patients
Among the 187 patients included (Fig. 1), 117 (54.7% male)
were culture-positive for H. pylori. The median age was
40.0 years (mean, 44.3 years; interquartile range (IQR) 31.0–
56.6 years; range, 14–93 years). The predominant ethnic
groups were Wolof (35.2%), Fulani (17.1%), and Serer
(15.2%), in keeping with the ethnic distribution in Senegal.
The most frequent presenting symptoms were weight loss
(n = 76, 65.0%), dyspepsia (n = 68, 58.1%), heartburn (n = 53,
45.3%), regurgitation (n = 50, 42.7%), anorexia (n = 49,
41.9%), nausea (n = 43, 36.8%) and dysphagia (n = 34, 29.1%).
vacA typing and diversity
Multiple vacA alleles were detected in 12 cases. These
patients were excluded from subsequent analyses. The
results of vacA typing among the remaining 105 patients are
shown in Table 2. All s1m1 strains were type i1, whereas all
s2m2 strains were type i2. Most of the strains had presumed
high-vacuolization isotypes (s1i1m1 (n = 60, 57.1%) or
s1i1m2 (n = 23, 21.9%)).
Endoscopic and histological ﬁndings
On the basis of endoscopic ﬁndings, 29 of the 105 patients
had gastritis only (12 males; median age, 38.5 years;
IQR 32.0–54.4), 61 had ulcerated lesion (38 males; median
age, 40.0 years; IQR 31.0–50.9), and 15 had suspicion of neo-
plasia (eight males; median age, 59.0 years; IQR 55.6–67.1).
All cases of suspected neoplasia were histologically con-
ﬁrmed as GC. Histological evaluations and the correlation
with endoscopic ﬁndings are shown in Table 3.
cagA status
The cagA gene was successfully ampliﬁed in 77 (73.3%) of the
105 H. pylori isolates. The absence of cag PAI was conﬁrmed
by empty site PCR in all 28 cagA-negative strains.
Mixed infection
Five patients had possible mixed infection, as one or more
nucleotide positions showed ambiguities after sequencing of
FIG. 1. Flow chart.
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the EPIYA PCR product. ES PCR gave negative results in all
of these patients, indicating the absence of cag PAI-negative
strains in the mixture. Two different RAPD banding patterns
among the ten isolates from each patient were observed in
all ﬁve patients, indicating the presence of two different
clones. Seventeen (14.5%) of the 117 H. pylori-positive
patients (including the 12 patients with multiple vacA alleles)
had evidence of mixed infection. As all isolates from individ-
ual patients yielded EPIYA PCR products of identical size and
an identical vacA allele, one representative isolate from each
RAPD banding pattern was analysed for EPIYA diversity (ten
in total).
EPIYA diversity
The EPIYA diversity of 82 H. pylori clones was analysed,
revealing the presence of EPIYA-A, EPIYA-B and EPIYA-C
segments. The four segments most frequently detected
within each EPIYA segment are shown in Table 4. All of the
strains shared the TIDD motif following EPIYA in segment C,
except for one strain with a TIED motif. QVNK and QVAK
occupied this position in all segments A and B, respectively.
The EPIYA combinations were ABC (n = 75, 91.5%), AB
(n = 3), ABCC (n = 2), AABC (n = 1), and BC (n = 1).
All gastroduodenal disorders were associated with a high
frequency of strains possessing an EPIYA ABC combination:
80.0% (12 of 15) in GC, 90.7% (39 of 43) in ulcerated
lesions, and 100.0% (19 of 19) in the remaining patients. The
only two strains with an EPIYA ABCC combination were
recovered from patients with GC.
Univariate analysis of factors associated with
H. pylori-related diseases and histological types
Among the 105 patients analysed, no correlation was found
between histological ﬁndings and either the vacA isotype or
cagA status (p >0.2). Univariate analysis showed no correla-
tion between ulcerated lesions and cagA status, EPIYA diver-
sity, or vacA isotype (p >0.2), whether the comparator group
was ‘other lesions’ or ‘gastritis only’. As a result, multivariate
analysis was not used to identify determinants of ulcerated
lesion.
TABLE 2. Risk factors for gastric cancer
Lesion Univariate analysis Multivariate analysis
Gastric cancer Other OR 95% CI p-value OR 95% CI p-value
Age (years), mean (SD) 58.8 (13.4) 41.8 (15.8) 1.06 1.03–1.11 0.001 1.10 1.04–1.16 <0.001
Gender, n (%)
Male 8 (13.8) 50 (86.2) 1 – 0.87
Female 7 (14.9) 40 (85.1) 1.1 0.36–3.27
cagA, n (%)
Absent 1 (3.6) 27 (96.4) 1 – 0.09 1 – 0.03
Present 14 (18.2) 63 (81.8) 6.0 0.75–47.9 17.7 1.3–241
Two EPIYA-C segments, n (%)
No 12 (16.0) 63 (84.0) 1 – 0.03
Yes 2 (100) 0 (0) 5.1 2.8–9.7
vacA s, n (%)
s1 15 (17.6) 70 (72.9) – – 0.002
s2 0 (0) 20 (100) – –
vacA m, n (%)
m1 12 (20.0) 48 (80.0) 1 – 0.07
m2 3 (6.8) 41 (93.2) 0.29 0.08–1.1
vacA i, n (%)
i1 14 (17.1) 68 (82.9) 1 – 0.15
i2 1 (4.3) 22 (95.7) 0.22 0.03–1.8
vacA si, n (%)
Others 1 (4.3) 22 (95.7) 1 – 0.16
s1i1 14 (17.1) 68 (82.9) 4.5 0.56–36.4
vacA smi, n (%)
Others 3 (6.7) 42 (93.3) 1 – 0.05 1 – 0.30
s1i1m1 12 (20.0) 48 (80.0) 3.5 0.92–13.2 2.2 0.5–10.3
SD< standard deviation.
TABLE 3. Correlation between the endoscopic and the his-
tological ﬁndings (no. (%))
Histological
ﬁnding Gastritis
Ulcerated
lesion
Suspicion of
neoplasia Total
Gastritis without any
other lesion
1 (3.5) 5 (8.2) 0 6 (5.7)
ACG as the most
severe lesion
4 (13.8) 5 (8.2) 0 9 (8.6)
IM as the most
severe lesion
24 (82.7) 49 (80.3) 0 73 (69.5)
LGD as the most
severe lesion
0 2 (3.3) 0 2 (1.9)
GC 0 0 15 (100) 15 (14.3)
Total 29 (100) 61 (100) 15 (100) 105 (100)
ACG, atrophic chronic gastritis; GC, gastric cancer; IM, intestinal metaplasia;
LGD, low-grade dysplasia.
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Factors associated with GC were older age, s1-type vacA,
and two EPIYA-C segments (Table 2). However, the latter
two factors could not be included in the multivariate analysis,
owing to sampling zeroes. The univariate p-values of these
two factors are therefore considered.
Multivariate analysis of factors associated with GC
The two models used to identify determinants of GC were
similar. Only cagA status and older age were independently
associated with GC. No statistically signiﬁcant interaction
was found. As this model showed a poor ﬁt (p 0.04), smi
allele status was added to the ﬁnal model, which allowed us
to include s1 allele status (Table 2). This latter model ﬁtted
well (p 0.37): the area under the receiver operating charac-
teristic curve was 0.87, the sensitivity was 80.0%, and the
speciﬁcity was 83.3%.
A third model was used to compare the 17 patients with
GC or dysplasia with the other patients. This model was
similar to the previous one, but had lower sensitivity and
speciﬁcity (76.4% and 78.4%, respectively).
Discussion
On the basis of age-standardized incidence rates, Senegal is
classiﬁed as a country with a low risk of GC (data available
at http://globocan.iarc.fr/). Seven different genetic populations
of H. pylori have been described worldwide, and their distri-
bution is closely related to the distribution of the incidence
of GC [18]. In Africa, where most strains are assigned to
hpAfrica1, the incidence of GC is low, although the incidence
is probably underestimated, owing to limited access to
healthcare facilities and short life-expectancies of popula-
tions. The genetic background might be a marker of viru-
lence factors directly involved in clinical outcome. Seventy-
nine of our 105 isolates have been randomly selected for
multilocus sequence analysis with a previously described
method [19], and all were assigned to hpAfrica1 (S. Breurec,
unpublished data).
The cagA gene was present in 73.3% of our isolates, a
proportion similar to that reported elsewhere in Africa
[9,10]. As in many western studies [20], cagA-positive strains
were signiﬁcantly associated with GC in Senegal. To the
best of our knowledge, such an association has never previ-
ously been described in an African population, probably
owing to insufﬁcient data for individual countries in previous
studies. CagA protein EPIYA segment diversity has been sug-
gested to be a major determinant of H. pylori pathogenesis.
As strains with multiple EPIYA-C segments were recovered
only from patients with GC, we were unable to measure
the strength of the association between these two factors in
multivariate analysis. However, in univariate analysis, the
presence of two EPIYA-C segments was associated with an
increased risk of GC. SHP-2 speciﬁcally binds to the tyro-
sine phosphorylated EPIYA-C segment of CagA, resulting in
the stimulation of SHP-2 phosphatase activity [21]; this
deregulation is involved in a variety of human malignancies
[22]. Strains with a higher number of EPIYA-C segments
exhibit a stronger propensity to interact with SHP-2, and
are more closely associated with precancerous lesions and
GC [23,24].
Although most of the patients had intestinal metaplasia as
their most severe lesion, the small proportion of strains har-
bouring at least two EPIYA-C segments (2.4%) relative to
other continents (11.5–30%) is one of our most important
ﬁndings [15,23–27]. In the only other study of isolates from
African patients (South Africa), 27% of H. pylori isolates con-
tained two or more EPIYA-C segments, but this discrepancy
could be attributable to the selection criteria, as 45% of
patients in the South African study had GC [12]. Thus, the
low prevalence of strains with multiple EPIYA-C segments
might contribute to the low incidence of GC in Senegal and,
by extension, in Africa, although further studies are needed
to evaluate their prevalence in other African countries.
Here, we investigated vacA region i for the ﬁrst time in
strains from an African population. The vacA s1 genotype
was linked to an increased risk of GC in univariate analysis,
as already suggested in a meta-analysis of African studies
[11]. Its presence in all the strains associated with GC pre-
vented us from measuring the strength of the association in
multivariate analysis. Type m1, which was also found to be a
risk factor for GC in the meta-analysis, was not associated
with an enhanced risk of GC in our study, possibly owing to
the small sample size. i1-type strains have been strongly
associated with GC in Iranians [7], but not in East Asian or
TABLE 4. The four most frequent EPIYA motifs among 82
cagA-positive isolates from 77 Senegalese patients. Bold
type indicates the polymorphic sites
n (%)
EPIYA-A motif
KELNEKFKNFNNNNNGLKNGKDKGPEEPIYAQVNKKKTGQVA 44 (53.6)
KELNEKFKNFNNNNN-GLKNSTEPIYAQVNKKKTGQVA 9 (11.0)
KELNEKFKNFNNNNN-GLKNGGEPIYAQVNKKKTGQVA 7 (8.5)
KELNEKFKNFNNNNN-GLKNSGEPIYAQVNKKKTGQVA 5 (6.1)
EPIYA-B motif
TGQVASPEEPIYAQVAKKVTQKIDQLNQAASGFGGVGQAG 23 (28.0)
TGQVASPEEPIYAQVAKKVSAKIDQLNQAASGFGGVGQAG 14 (17.1)
TGQVASPEEPIYAQVAKKVTKKIDQLNQAASGFGGVGQAG 13 (15.9)
TGQVASPEEPIYAQVAKKVNAKINQLNQAASGFGGVGQAG 13 (15.9)
EPIYA-C motif
FP-LKRHDKVDDLSKVGRSVSPEPIYATIDDLGGS 25 (30.5)
FP-LKRHDKVEDLSKVGRSVSPEPIYATIDDLGGS 15 (18.3)
FP-LKRHDKVDDLSKVGRSVSPEPIYATIDDLGGP 8 (9.8)
FP-LKKHDKVEDLSKVGRSVSPEPIYATIDDLGGS 7 (8.5)
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Southeast Asian populations [28]. The lack of association
between the i1 type and GC in Senegalese patients highlights
the difﬁculty of extrapolating results from one geographical
area to another.
The main bias in most studies of H. pylori mixed infection is
that bacterial heterogeneity within individuals is not exten-
sively assessed. We tried to overcome this weakness by using
an approach based on H. pylori isolation from gastric biopsy
samples obtained with the sweeping method, followed by
molecular investigations [15]. Fourteen per cent of our
patients had evidence of mixed infection. This, combined with
data from South Africa [29], suggests that mixed infections
are common in African populations. Knowledge of the preva-
lence of mixed infections in a given population is of major
importance. Indeed, recombination during mixed infection has
been identiﬁed as a major driving force behind allelic diversity
in H. pylori, which may affect individual disease outcomes.
The data reported here are particularly important, given
the difﬁculty of carrying out such studies in hospitals in coun-
tries with inadequate healthcare systems. Consequently,
most data on H. pylori and GC in Africa are from South
Africa. The lack of systematic gastric biopsies during upper
gastrointestinal tract endoscopy explains the over-represen-
tation of ulcerated lesions and GC in our study population.
Even though our ﬁndings may not be representative of the
overall situation, it should be noted that the study took place
in one of the main tertiary hospitals in Senegal. Despite the
small number of GC cases studied, we found that increasing
age and the presence of cagA, two EPIYA-C segments and
the s1 vacA allele were associated with GC, suggesting that
the relationship is robust. Our isolates were characterized
by a lower prevalence of multiple EPIYA-C segments than
reported in other countries, which may partly explain the
low incidence of GC in Senegal.
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